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Background: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians
particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use
needs to be critically appraised because it may differ from approved on-label usage. Therefore, an extensive
exploration of current evidence on clinical data is well-advised. The objective of this study was to develop a search
strategy that facilitates detection of the off-label drug use documents in EMBASE via OvidSP.
Methods: We constructed two sets of gold standards from relevant records to off-label drug use by a sensitive
search of MEDLINE and EMBASE. Search queries, including search words and strings, were conceived based on
definition of off-label use of medications as well as text analysis of 500 randomly selected relevant documents. The
selected terms were searched in EMBASE (from 1988 to 2011) and their retrieval performance was compared with
the gold standards. We developed a sensitivity-maximizing, and a sensitivity- and precision-maximizing search
strategy.
Results: From 4067 records relevant to off-label drug use in our full gold standard set, 3846 records were
retrievable from EMBASE. “off label*.af.” was the most sensitive single term (overall sensitivity 77.5%, sensitivity
within EMBASE 81.9%, precision 88.1%). The highest sensitive search strategy was achieved by combining 36 search
queries with overall sensitivity of 94.0% and precision of 69.5%. An optimal sensitive and precise search strategy
was yielded precision 87.4% at the expense of decreasing overall sensitivity to 89.4%.
Conclusion: We developed highly sensitive search strategies to enhance the retrieval of studies on off-label drug
use in OvidSP EMBASE.
Keywords: Off-label use, Information retrieval, EMBASE, MEDLINE, SensitivityBackground
Pharmacotherapy is usually based on drugs that are
approved for specific indications, dosages, routes of ad-
ministration, or populations. However, administration of
drugs outside these approved purposes is possible and
denoted “off-label drug use”. Off-label drug use is com-
mon practice, but generally suffers from a lack of suffi-
cient evidence on risk/benefit assessment [1-4]. For
some drugs off-label use is clinically more important
than for approved purposes. For example, in a recent re-
port off-label use of factor VII was found to be more fre-
quent than its on-label indications [5]. Nonetheless,* Correspondence: harald.herkner@meduniwien.ac.at
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distribution, and reproduction in any mediumthere is increased effort to provide an evidence base for
off-label use of drugs. Therefore, it appears important to
explore the best strategy to find as many relevant studies
as possible.
Free access to MEDLINE through the PubMed inter-
face and its broad coverage makes it the first-choice
database in biomedical literature [6,7]. Excerpta Medica
Database (EMBASE) is also considered as a major biblio-
graphic database in biomedicine but it is only available
by subscription [8,9]. EMBASE covers pharmacology,
pharmaceutical science and clinical research as its main
areas of interest. In comparison with MEDLINE, it pro-
vides more extensive coverage of European and non-
English language publications [10] as well as conference
abstracts [9].ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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LINE only are generally not advised, because of potential
introduction of retrieval bias [11-14]. Moreover, each
bibliographic database has different indexing practice
and thesaurus system. For example, records in MED-
LINE are indexed using the National Library of Medi-
cine’s controlled vocabulary Medical Subject Headings
(MeSHW) and EMBASE uses a thesaurus called
EMTREE, which includes medical terms, drug names,
acronyms, MeSHW headings and spelling variations.
Therefore, even within one interface like OvidSP a
search strategy is specific for a particular database. It is
unclear whether a search strategy can be directly trans-
lated for applying in other databases, without loss of
sensitivity or precision [15]. This may result in missing
studies or retrieving many irrelevant documents. In a re-
cent study, we found that MEDLINE did not cover 46%
of off label drug use studies [16]. As a consequence we
set out here to report the retrieval properties of selected
search queries and combined queries for identifying off-
label drug use studies in EMBASE.
Methods
Our methods are detailed elsewhere [16]. Briefly, we did
a systematic and sensitive search in MEDLINE and
EMBASE through OvidSP (from 1948 and 1988, respect-
ively; last updated in 28 February 2011) to find studies
on off-label use of drugs. We constructed two sets of
gold standards: the external or full set gold standard
contained the whole relevant records retrieved from
these two databases; the internal gold standard was the
subset of documents indexed in EMBASE. Search quer-
ies and strategies were then created and tested for theirSensitivity ¼ number of relevant records in a database retrieved by a search strategy
total number of relevant records in the database
 100ability to retrieve relevant records in EMBASE. We
assigned a search query as one line in a search strategy.
It is usually a text string containing the exact sequencePrecision ¼ number of relevant records retrieved by a search strategy
total number of records retrieved by the search strategy
 100of words and/or characters, and may include Boolean or
proximity operators. Consequently, a search strategy con-
sisted of several search queries connected with Boolean
operators.
To construct a comprehensive set of possible search
queries, we expanded our list of controlled vocabulary
search terms or subject headings (EMTREE inEMBASE), text words and strings by text analysis of 500
random documents in the gold standard full set. We ap-
plied frequently used fields in OvidSP EMBASE for
searching like “.af.” for all searchable fields, “.ab.” for ab-
stract, “.ti.” for title and “.mp.”, which restricts OvidSP's
search to the text of title, abstract, subject headings,
heading word, drug trade name, original title, device
manufacturer or drug manufacturer name. We also used
the Boolean operators “OR”, “NOT”, and proximity
operator “ADJ[Number]”, as well as truncation and
wildcards.
We considered documents as relevant to off-label drug
use, if they referred to any human drug outside the ap-
proval purposes, in terms of different dose, indication,
route of application or for another age group. We did
not apply any language restrictions, but method-wise we
excluded book series, videos, errata, and corrections. We
created a Microsoft (MS) Access database to store and
manage all records retrieved by the search queries.
We compared the retrieval performance of each candi-
date term and combination of queries with the internal
gold standard reference set by determining their sensitiv-
ity, precision and number needed to read (NNR). We
chose an external gold standard in addition to the
EMBASE gold standard to establish the general perform-
ance of our search strategies, supplementary to the per-
formance which is driven by EMBASE indexing. Hence,
we defined “overall sensitivity” as the number of relevant
records in EMBASE retrieved by a search query/strategy
divided by the total number of relevant records in the
full gold standard set.
Sensitivity for a given search is defined as the propor-
tion of relevant records retrieved from the database:Precision is the proportion of relevant records
retrieved in the search, which is equivalent to positive
predictive value:The NNR refers to the number of non-relevant records




Figure 1 Flow diagram of retrieval and screening process for
the gold standard set.
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search strategy (HSSS) with two optimized versions: (1)
a sensitivity-maximizing version and (2) a sensitivity-
and precision-maximizing version.
For the development of search strategies to optimize
sensitivity or precision, we tested all combination of
search queries by using an algorithm programmed in C+
+. The search strategy with the highest balance of sensi-
tivity and precision was developed by creating the scatter
plot of precision versus sensitivity and calculating their
best trade-off for the combined queries.
For hypothesis testing we used the Fisher's exact test
for independent data and the McNemar test for corre-




From 6,785 unique records, which were retrieved by a
systematic search in MEDLINE and EMBASE via
OvidSP, we classified 4,067 as relevant records to off-
label drug use. This constituted our full gold standard
set (Figure 1). This set included 3,846 records retrievable
within EMBASE, which was 62.5% of total retrieved
records in EMBASE; among them, 3,480 (90.5%) were
published between years 2001-2011.
Search results
We evaluated the performance of 77 search queries and
their combinations. In Table 1, we present the perform-
ance of the 15 search queries with the highest sensitivity
(see Additional file 1 for the full list). “off label*.af.”
yielded the highest sensitivity among the single terms
(overall sensitivity 77.5%, sensitivity within EMBASE
81.9%, precision 88.1%). Most of the top performing
search queries had NNR of 1.1, which indicates that al-
most every abstract read classifies on off-label drug use.
Truncation “off label” resulted in retrieving 35 more
records, of which 31 (88.6%) were relevant. It retrieved
more relevant records than “(off adj2 label*).mp.”, al-
though the latter retrieved two unique records.
The overall sensitivity of search query "off label" and its
truncation increased by 10.4% when we broadened their
field from abstract (.ab.) to abstract and title (.ab,ti.). The
most specific subject heading was "off label drug use". Ex-
ploding this to all its subheadings, "off label drug use".sh.,
resulted in 36.8% overall sensitivity (sensitivity within
EMBASE 38.9%). Truncating the text string "off label drug
use" and then applying all field (.af.) slightly increased its
overall sensitivity to 38.1% and 38.8%, respectively.
We retrieved substantial non-relevant records after
searching “label adj1 us*.af.” consisted of the following
terms: “using label-free” indicating different types of
label-free proteomics technologies; “extra-label use”referring the off-label use of veterinary drugs; “open-
label use” as a type of study; “spin label using” specifying
a tool to study the structure of proteins and biological
membranes; and “food/nutritional label use” ascribing
the information provided on food products.
To improve the precision of search term “inappropri-
ate us*”, we excluded the records about rational drug
use and polypharmacy by NOTing out “antibiotic* or
antimicrobial”. The precision of search term “unlicense*.
af.” was improved by 30% and its NNR declined about
two fold by eliminating retrieval of irrelevant content. It
resulted by NOTing out an ORed string of 31 search
terms prevalent in its irrelevant records retrieved (see
Additional file 1).
To find the relevancy of some retrieved records, par-
ticularly those with no abstract such as the letters we
had to read their full text. Whenever we detected some
relevant editorial, letter or commentaries on other stud-
ies, we checked the retrieval status of cited study, conse-
quently. In some cases, we found that we had not
retrieved the relevant cited study through our search
Table 1 Sensitivity, precision and number needed to read (NNR) of the 15 search queries in OvidSP EMBASE with the
highest sensitivity (see the complete list in Additional file 1)











off label*.af. 3150 3577 77.5 81.9 88.1 1.1
(off adj2 label*).mp. 3131 3589 77.0 81.4 87.2 1.1
(off adj1 label*).mp. 3130 3567 77.0 81.4 87.7 1.1
off label*.mp. 3128 3555 76.9 81.3 88.0 1.1
off label.af. 3119 3542 76.7 81.1 88.1 1.1
(off adj1 label).mp. 3119 3544 76.7 81.1 88.0 1.1
(off adj2 label).mp. 3119 3547 76.7 81.1 87.9 1.1
off label.mp. 3117 3540 76.6 81.0 88.1 1.1
"off label*".ab,ti. 2306 2696 56.7 60.0 85.5 1.2
off label.ab,ti. 2293 2679 56.4 59.6 85.6 1.2
"off label*".ab. 1882 2224 46.3 48.9 84.6 1.2
off label.ab. 1870 2208 46.0 48.6 84.7 1.2
(drug adj2 label adj2 us*).af. 1587 1719 39.0 41.3 92.3 1.1
(drug adj1 label adj1 us*).af. 1581 1710 38.9 41.1 92.5 1.1
"off label drug us*".af. 1580 1677 38.8 41.1 94.2 1.1
¶ADJn is a positional operator to retrieve records that contain the terms (in any order) within a specified number (n) of words of each other. The adj1 operator
finds two terms next to each other in any order. The adj2 operator finds terms in any order and with one word (or none) between them.
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[17] on a study of Acharya and associates [18] about off-
label use of ranibizumab in uveitis. However, none of
our search queries could retrieve the respective original
article, despite our text analysis showed that the term
“off-label” has been used four times in the full-text of
Acharya paper [18].
Final search strategies
We constructed the best performing search strategy in
terms of maximized sensitivity by “OR” combination of
32 search queries. This resulted in an overall sensitivity
of 93.98% (99.38% within EMBASE) and a precision of
69.48% (Table 2). Enhancement of sensitivity and preci-
sion after incrementally ORing new search queries is
shown as cumulative sensitivity and precision in Table 2.
Overall sensitivity and precision of the EMBASE HSSS
(sensitivity maximized) was higher in the recent years
(2001-2011) compared to years 1988-2000 (95.6% vs
79.3% and 75.0% vs 40.8%, p<0.001 for both), while sen-
sitivity within EMBASE remained approximately con-
stant (99.5% vs 99.4%; p=0.99, Fisher exact test).
We also tested the EMBASE HSSS (sensitivity maxi-
mized) in the full gold standard set excluding 500
records that used to develop our strategies and received
virtually the same results.
To evaluate the retrieval function of off-label drug use
search strategy developed for a different database, we fur-
ther tested our published search strategy for OvidSP
MEDLINE [16] in OvidSP EMBASE. The retrieval impli-
cations of re-running our published highly sensitive searchstrategy A for OvidSP MEDLINE (MEDLINE HSSS) in
EMBASE yielded an overall sensitivity of 89% and a sensi-
tivity within EMBASE of 94%, precision of this search
strategy was 77.7%. Using the EMBASE HSSS (sensitivity
maximized) compared with the published MEDLINE
HSSS (sensitivity maximized) in EMBASE increased sensi-
tivity from 94% to 99% (p <0.001, McNemar test). Out of
4,067 studies classified relevant in the full set gold stand-
ard, 1,942 studies were retrieved through EMBASE HSSS
in EMBASE as well as the MEDLINE HSSS in MEDLINE
(both sensitivity maximized). By searching in MEDLINE
only, 1,880 relevant records were not retrieved whereas by
searching in EMBASE only, 222 were not retrieved
(p<0.001, McNemar test).
We plotted precision versus overall sensitivity of
search query combinations to optimize sensitivity and
precision (Figure 2). Table 3 shows the most parsimoni-
ous search strategy amongst 15 strategies where sensitivity
was optimized for high precision (see Additional file 2).
The combination of 22 search queries and query “(stent*
or veterinar*).af.” by using a NOT operator eliminated the
irrelevant records out of the most optimized sensitive
and precise search strategy leading to 5.32% improve-
ment of precision at the cost of a small decrease in
sensitivity (overall and within EMBASE 0.37% and 0.39%,
respectively).
OvidSP EMBASE characteristics
A substantial change in number of retrieved records in
EMBASE was found in early August 2010. 206 dupli-
cated and two triplicated records were retrieved in our
Table 2 Highly Sensitive Search Strategy for identifying off-label drug use reports in OvidSP EMBASE: sensitivity-
maximizing version














1 off label*.af. 3150 3577 77.45 81.90 88.06
2 (off adj1 label).mp. 3152 3581 77.50 81.96 88.02
3 (drug adj2 label adj2 us*).af. 3153 3617 77.53 81.98 87.17
4 unlicense*.af. 3279 4320 80.62 85.26 75.90
5 unapprove*.af. 3445 4635 84.71 89.57 74.33
6 (label adj3 indication*).af. 3450 4667 84.83 89.70 73.92
7 off li?en?e*.af. 3509 4742 86.28 91.24 74.00
8 ((no* licen?ed for adj3 use*)
not now licen?ed).af.
3560 4825 87.53 92.56 73.78
9 ((inappropriate us* and indication)
not (antibiotic* or antimicrobial)).af.
3609 4964 88.74 93.84 72.70
10 ((appropriate* adj3 prescri*) and
indication).af.
3648 5081 89.70 94.85 71.80
11 (outside adj3 licen?e*).af. 3665 5110 90.12 95.29 71.72
12 unlabel* us*.af. 3692 5140 90.78 96.00 71.83
13 labeled indication*.af. 3703 5169 91.05 96.28 71.64
14 (inappropriate indication*).af. 3719 5294 91.44 96.70 70.25
15 nonapprove*.af. 3737 5337 91.89 97.17 70.02
16 registered indication*.af. 3752 5367 92.25 97.56 69.91
17 offlabel*.af. 3757 5372 92.38 97.69 69.94
18 (out* adj4 licen?ed indication*).af. 3759 5376 92.43 97.74 69.92
19 (unlabel* adj3 indication*).af. 3767 5384 92.62 97.95 69.97
20 non fda approve*.af. 3780 5411 92.94 98.28 69.86
21 ((no* licen?ed for adj3 indication*)
not now licen?ed).af.
3793 5425 93.26 98.62 69.92
22 (appropriate indication adj3 us*).af. 3796 5432 93.34 98.70 69.88
23 (be???d* adj2 licen?ed indication*).af. 3799 5436 93.41 98.78 69.89
24 (us* without adj2 indication*).af. 3804 5445 93.53 98.91 69.86
25 (prescri* outside adj4 guideline*).af. 3808 5450 93.63 99.01 69.87
26 (out of label).af. 3810 5466 93.68 99.06 69.70
27 (improper adj1 indication*).af. 3812 5472 93.73 99.12 69.66
28 (inappropriate adj5 indication adj2
us*).af.
3814 5475 93.78 99.17 69.66
29 no* appropriate indication*.af. 3815 5482 93.80 99.19 69.59
30 (non evidence base* us*).af. 3818 5487 93.88 99.27 69.58
31 without proper indication*.af. 3821 5498 93.95 99.35 69.50
32 (or/1-31) or (drug* without adj2
indication*).af.
3822 5501 93.98 99.38 69.48
Combinations of search queries with the best sensitivity are ranked in descending order of number of relevant records.
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accession numbers but mostly in the same entry week.
For example, a study by Caron [19] had two records
with two accession numbers and similar entry week
(17872714 and 2007205136; entry week: 200700) and a
study by Daskalaki et al. [20] had two records with two
accession numbers and two entry weeks: 18595974
(entry week: 200800) and 2009161626 (entry week:200900) (see Additional file 3). Moreover, we came
across to some other errors such as dup/triplicate
records because of typographical errors or more than
one translation for non-English titles. For example, a
study by Konda et al. [21] recorded in two different titles
“Colchicine in dermatology” and “Dosages and adminis-
tration”. The latter title is wrong and this record has also
failed to provide author’s name and had a typo error in
Figure 2 Plot of sensitivities (relevant documents in the overall set (n=4,067) and within EMBASE (n=3,846)) versus precision for
different combinations of search queries to detect studies on off-label drug usage in electronic databases.
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indexed with 10 subject headings and the wrong one
with 56 subject headings including “off label drug use”
(see Additional file 3). We also found that indexing for
documents that are published in more than one journal
might be different. It is also the case when a document
is published as both a conference abstract and an article.
For example, a study by De Jong et al. which is pub-
lished as a conference abstract [22] and an article [23]
was indexed with 15 subject headings where publication
type was 'abstract' and with 36 subject headings includ-
ing “off label drug use” where publication type was 'art-
icle'. The abstracts recorded for these two publication
types were almost the same (see Additional file 3). How-
ever, the database issues presented do not appear to ex-
plain much of the performance limitations overall.
The sensitivity and precision of some search queries
was different after replacing the “af” field by “mp” in our
last update, 28 February 2011. Therefore, we chose the
best balance of sensitivity and precision (see Additional
file 1). However, running our search queries in 30 January
2012 showed that the discrepancies between these two
search fields have been removed. Updating issues during
the integration of records from MEDLINE into the
OvidSP EMBASE database may explain this (e-mail com-
munication with Ovid Training Department).
Discussion
We developed highly sensitive search strategies for OvidSP
EMBASE to enhance the retrieval of studies on off-labeldrug use. These highly sensitive search strategies outper-
formed single search terms, EMTREE terms, and queries
as well as search strategies designed for another database.
Top-performing queries were almost the same in
EMBASE compared to our published search queries
developed for MEDLINE [16]. For example, the queries
“off label*.af.”, “(off adj2 label*).mp.” and “(off adj1
label*).mp.” were all top performers in both databases.
Three queries “(unlabel* adj3 indication*).af.”, “(unap-
prove* adj5 prescription).af.” and “(outside adj3 licen?e*).
af.” were only selected for EMBASE. We also chose “off
label.mp.” because of different retrieval for search fields
“af” and “mp” in EMBASE. Furthermore, the most spe-
cific subject heading was not exactly identical in two
databases: "off label drug use" in EMBASE and "Off-
Label Use" in MEDLINE.
Optimized strategies, sensitivity-maximizing version
and sensitivity- and precision-maximizing version, in
EMBASE had greater overall sensitivity (sensitivity in
the full gold standard set) and precision than the com-
parable MEDLINE strategy. However, the sensitivity
within their internal gold standard was almost the same.
This can be best explained by different coverage of these
databases. For example, a study showed that 47% of 386
Syrian Arab Republic reports indexed in MEDLINE or
EMBASE were found exclusively in EMBASE, while 32%
from MEDLINE alone and 21% from both of them [24].
Moreover, by the integration of records from MEDLINE
into EMBASE, the coverage of EMBASE must have
increased [25].



















1 off label*.af. 3150 3577 77.45 81.90 88.06
2 (unlicensed not (unlicensed aide* or unlicensed assist* or
unlicensed car* or (Unlicensed adj2 heal*)or unlicensed
home* or (killer adj2 cell*) or (unlicensed adj2 individual*)
or (unlicensed adj2 nurs*) or (unlicensed adj4 practi*) or
(unlicensed adj2 physician*) or (unlicensed adj2 operat*)
or (unlicensed adj2 person*) or unlicensed profession* or
unlicensed rid* or (unlicensed adj3 staff*) or unlicensed
therapist* or (unlicensed adj5 vaccine*) or unlicensed
vendor* or (unlicensed adj2 work*) or (unlicensed adj2
employe*) or device*or dentist*or driver or driving or
herbal or medical graduate* or motor* or pesticide*or
premis*or prostitute*or restaurant*or veterinary or
worker*)).af.,
3272 3858 80.45 85.08 84.81
3 (unapprove* adj2 us*).af. 3331 3947 81.90 86.61 84.39
4 (unapprove* adj5 indication*).af. 3367 3986 82.79 87.55 84.47
5 off li?en?e.af. 3425 4053 84.21 89.05 84.51
6 ((no* licen?ed for adj3 use*) not now licen?ed).af. 3476 4136 85.47 90.38 84.04
7 (unapprove* adj2 drug*).af. 3493 4181 85.89 90.82 83.54
8 (outside adj3 licen?e*).af. 3511 4211 86.33 91.29 83.38
9 unlabel* us*.af. 3538 4241 86.99 91.99 83.42
10 labeled indication*.af. 3549 4270 87.26 92.28 83.11
11 nonapprove*.af. 3569 4317 87.76 92.80 82.67
12 registered indication*.af. 3585 4348 88.15 93.21 82.45
13 offlabel*.af. 3590 4353 88.27 93.34 82.47
14 (unlabel* adj3 indication*).af. 3598 4361 88.47 93.55 82.50
15 non fda approve*.af. 3611 4388 88.79 93.89 82.29
16 ((no* licen?ed for adj3 indication*) not now licen?ed).af. 3624 4402 89.11 94.23 82.33
17 (appropriate indication adj3 us*).af. 3630 4413 89.25 94.38 82.26
18 (be???d* adj2 licen?ed indication*).af. 3633 4417 89.33 94.46 82.25
19 (us* without adj2 indication*).af. 3638 4428 89.45 94.59 82.16
20 (prescri* outside adj4 guideline*).af. 3643 4434 89.57 94.72 82.16
21 (inappropriate adj5 indication adj2 us*).af. 3647 4441 89.67 94.83 82.12
22 (non evidence base* us*).af. 3650 4446 89.75 94.90 82.10
23 (or/1-22) not (stent* or veterinar*).af. 3635 4158 89.38 94.51 87.42
Combinations of search queries with the best optimization of sensitivity and precision are ranked in descending order of number of relevant records. See further
search strategies in Additional file 2.
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adapted to the indexing structure, limits, and special fea-
tures for each database is extensively reported, although
there is no study on retrieval failure [15]. Re-running a
highly sensitive search strategy which we developed for
identifying off-label drug use in OvidSP MEDLINE [16]
in OvidSP EMBASE achieved about 5% less sensitivity
compared to our newly developed search strategy, but
8.2% higher precision.
Retrieving relevant studies on off-label drug use might
be influenced by many mechanisms such as low quality of
off-label use reporting and poor indexing in bibliographicdatabases. Administration of medication for unapproved
purposes is not well defined or properly described in some
reports. This might happen when authors are inconsider-
ate or unfamiliar with the concept. A survey of 95 office-
based pediatricians in France showed that they did not
recognize the off-label status of 686 out of 745 (92%) drug
courses they commonly prescribed [26]. Another study in
Northern Ireland on experience and attitudes of health-
care professionals on unlicensed/off-label pediatric pre-
scribing revealed that 41% of 563 respondents were not
familiar with the term “off-label medicines” prior to par-
ticipating in the study [27].
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authors), inconsistent terminology or ambiguous de-
scription in the abstract might lead to the poor indexing,
because the whole information contained in the full-text
record is not detected by searching in bibliographic
databases. Thus, low sensitivity of the specific EMTREE
term for off-label drug use studies in EMBASE, "off label
drug use".sh., confirmed inconsistent indexing. Another
indication of poor indexing is the fact that in some cases
secondary papers like letters, commentaries or editorials
could be retrieved but not the original papers. Glanville,
et al. showed that MEDLINE and EMBASE indexing
terms for economic evaluations are not efficient either.
They indicated that it could be explained by indexer un-
certainty and indexing lapses, in addition to poor report-
ing by authors [28].
As a result of the low quality of reporting off-label
drug use and poor indexing, we will not be able to re-
trieve all relevant records on off-label drug use by search
in bibliographic databases alone, even with the highest
sensitive search strategies. Thus, we suggest the imple-
mentation of our search strategy already for broad sweep
research questions. “Off-label drug use in multiple scler-
osis” or “off-label use of beta interferon” might serve as
an example.
Search queries included in EMBASE HSSS were the
same as MEDLINE HSSS in 81.3% (both sensitivity max-
imized strategy); the latter had one query less and the
differences between three out of five dissimilar queries
were due to the distance between two terms by using
proximity operator. For example, “unlabel* indication*.
af.” in MEDLINE HSSS was replaced by “(unlabel* adj3
indication*).af.” in EMBASE HSSS. Among 23 queries
included in EMBASE HSSS (sensitivity- and precision-
maximized), 11 queries were identical to the respective
MEDLINE strategy. It also included a very long query
(NOTed out “unlicensed”) and two more queries than
MEDLINE.
We found that using an exclusion strategy was effi-
cient to develop the optimized sensitive and precise
strategy. It resulted from attempts to remove irrelevant
studies whilst retaining sensitivity in two phases. The
first one resulted from improving the retrieval by elimin-
ating irrelevant content with search term “unlicensed”.
In the second phase, we excluded studies on off-label
use of medical devices, in particular stents, and veterin-
ary medications from the selected set of queries, as it
was the case in our prior study on developing a MED-
LINE strategy [16]. It is likely that NOT operators im-
pair sensitivity of a search [29,30] due to removing
relevant as well as irrelevant records. Alternatively, there
is a rather safe approach to use this operator. For ex-
ample, the Cochrane HSSS (sensitivity maximizing) for
identifying randomized trials in MEDLINE consisted ofa query “animals [mh] NOT humans [mh]” which is
combined by NOT to OR string of eight search terms
[31]. Thus, this strategy excludes reports solely of animal
studies, but retains reports indexed as human and ani-
mal, and neither human nor animal. Hence, we chose
the search terms to combine with NOT if they were fre-
quently used in the irrelevant records and rarely
appeared in the relevant records only. Nonetheless, the
sensitivity was slightly reduced as a consequence of ex-
cluding some relevant records. A recent study showed
that NOTing out irrelevant content could improve re-
trieval of original studies on diagnosis, prognosis and eti-
ology in MEDLINE, EMBASE, CINAHL and PsycINFO
[32]. We also truncated short words like “use” or “out”
within an exact sequence of words only. The truncated
short terms are not generally recommended because
they could retrieve many different words yielded low
precision due to retrieving irrelevant records and in
some database interfaces unexpected results may hap-
pen. Therefore, we carefully followed these short terms
with an “exact” sequence of words to decrease its pos-
sible “side effects” associated with irrelevant records
retrieval.
Conclusion
We developed highly sensitive search strategies for
OvidSP EMBASE to enhance the retrieval of studies on
off-label drug use. Our study demonstrates that a com-
prehensive search for off-label drug use in OvidSP
EMBASE can be much improved by highly sensitive
search strategies instead of using simple search terms.
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